PolyPid to Report First Quarter 2022 Financial Results and Operational Highlights on May 11, 2022

Meeting
April 2022

PETACH TIKVA, Israel, April 27, 2022 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2022 financial results and operational highlights before the

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon